Concepedia

Publication | Open Access

Targeted Therapy of <i>TERT</i> -Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy

31

Citations

31

References

2020

Year

Abstract

OTX015 and carfilzomib combination therapy is likely to be translated into the first clinical trial of a targeted therapy in patients with <i>TERT</i>-rearranged neuroblastoma.

References

YearCitations

Page 1